Compare Research Peptides

Select 2 peptides to compare benefits, dosage, administration routes, mechanisms, and side effect profiles side by side.

Peptide 1

Peptide 2

	LL-37 Cathelicidin Sign up to track	KPV Lysine-Proline-Valine Sign up to track
Evidence Grade	CEvidenceGrade CPrimarily animal or in-vitro studies; limited human data	CEvidenceGrade CPrimarily animal or in-vitro studies; limited human data
Regulatory	Research OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only	Research OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only
Category	Immune & Inflammatory Modulation	Immune & Inflammatory Modulation
Key Benefits	•Broad-spectrum antimicrobial effects •Modulates immune response •Promotes wound healing •Anti-inflammatory properties +2 more	•Strong anti-inflammatory effects •Gut healing properties •Reduces inflammatory cytokines •May help IBD and IBS +2 more
Dosage	5-10 mg mg	500-1000 mcg mcg
Frequency	2-3x weekly	1-2x daily
Administration	SubcutaneousIntramuscular	SubcutaneousOral
Mechanism	LL-37 is the only human cathelicidin, a natural antimicrobial peptide with broad-spectrum activity. It plays a crucial role in innate immunity and wound healing.	KPV is a C-terminal tripeptide of α-MSH with potent anti-inflammatory effects. It is being researched for inflammatory bowel disease and various inflammatory conditions.
Side Effects / Risks	Not specified	Not specified
Research Status	Research compound	Research compound